Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burke

Showing results (541-550 of 552) with videos related to

Pageof 56
Sort By:
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
The New England Journal of Medicine|May 20, 2024
A Modular Communicative Leadless Pacing-Defibrillator SystemReinoud E Knops, Michael S Lloyd, Paul R Roberts, et al.
Heart Rhythm O2|July 28, 2025
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trialJolien A de Veld, Lonneke Smeding, Mikhael F El-Chami, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Heart Rhythm|February 9, 2024
Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trialReinoud E Knops, Mikhael F El-Chami, Christelle Marquie, et al.
Circulation|April 25, 2026
Subcutaneous Defibrillator Implantation With or Without Defibrillation Test: The Primary Results of the Randomized PRAETORIAN-DFT TrialReinoud E Knops, Christelle Marquie, Peter Nordbeck, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN TrialLouise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, et al.
Pageof 56

Showing results (541-550 of 552) with videos related to

Sort By:
Pageof 56
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
The New England Journal of Medicine|May 20, 2024
A Modular Communicative Leadless Pacing-Defibrillator SystemReinoud E Knops, Michael S Lloyd, Paul R Roberts, et al.
Heart Rhythm O2|July 28, 2025
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trialJolien A de Veld, Lonneke Smeding, Mikhael F El-Chami, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Heart Rhythm|February 9, 2024
Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trialReinoud E Knops, Mikhael F El-Chami, Christelle Marquie, et al.
Circulation|April 25, 2026
Subcutaneous Defibrillator Implantation With or Without Defibrillation Test: The Primary Results of the Randomized PRAETORIAN-DFT TrialReinoud E Knops, Christelle Marquie, Peter Nordbeck, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN TrialLouise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, et al.
Pageof 56